💨 Abstract

PTC Therapeutics Inc. reported first-quarter earnings of $866.6 million, exceeding Wall Street expectations with a net income of $10.04 per share. Revenue was $1.18 billion, also surpassing forecasts. The Warren, New Jersey-based biopharmaceutical company's results were generated by Automated Insights using data from Zacks Investment Research.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖